Detailed price information for Spectral Medical Inc (EDT-T) from The Globe and Mail including charting and trades.

The Tigris Trial is a confirmatory study of PMX in addition to standard care vs standard care alone and is designed as a 2:1 randomized trial of 150 patients using Bayesian statistics. Endotoxic ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

The Elecsys Amyloid Plasma Panel, which received FDA Breakthrough Device Designation in July 2023, is a minimally invasive blood test that measures phosphorylated Tau (pTau) 181 protein and ...

A new drug combination could help breast cancer ... Described by scientists as "potentially transformative," this breakthrough therapy could offer new hope to those affected by this challenging ...

New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer's disease related amyloid pathology with very good accuracy.In the largest worl ...

The FDA Breakthrough Device designation for AutoChamberTM follows the FDA's recent clearance of HeartLung's AutoBMDTM, an AI-powered opportunistic bone density measurement test that works on any ...

SANTA CLARA , Calif., Oct. 30, 2024 /PRNewswire/ -- Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today that the U.S Food and Drug ...

Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence ... published details of its new AI drug discovery model, named "Enchant".

You can read more about these diagnostic and device innovations — plus others in a wide range of categories — at Time. DeviceTalks is a conversation among medical technology leaders. It's events, ...